SKICON 2023

1st International Conference

February 24-25, 2023

``Recent advances in translational research and molecular medicine.``

Prof. Shivajirao Kadam

Chief Patron

Dr. Rahul Kadam

Patron

SKICON’, the 1st International conference on

RECENT ADVANCE IN TRANSLATIONAL RESEARCH AND MOLECULAR MEDICINE will provide an open forum for the academicians, researchers, budding pharmacists, and professionals from pharmaceutical industry to enrich their knowledge in the area of drug discovery, development and regulatory requirements. It will help them to share their ideas and research work which may culminate with new concepts, innovations and novel strategies for various challenges in the pharmaceutical field.

The conference features keynote addresses by internationally renowned speakers from various countries expertise in different disciplines of pharmaceutical field. The conference will also provide the opportunity to young budding researchers , scientists and industry professionals from various organisations to put forth their innovative ideas and research findings by panel discussions, deliberations and poster presentation.

Impact – Expected Outcome- Academic / Social / Commercial

  • This conference will provide a strong base and knowledge about the latest developments in drug discovery.
  • It will be a platform to provide industry interaction, sharing of knowledge among academicians, researchers and industrialists.
  • It will display the latest developments, research and projects in the pharmaceutical.
  • The latest requirements of industry will be shared among all the academicians and researchers, which will lead to target the focus areas.

Prof. Piyush Trivedi

Advisor

Prof. KR Mahadik

Chairman SKICON

Dr. D. K. Jain

CO-Chairman SKICON

Dr. T. R. Saini

CO-Chairman SKICON

Dr. Sanjay T Purkar

Organizing Chairman

Dr. Moh Rizwan Khan

Organizing Secretary

Our Honorable

KEYNOTE SPEAKERS

Dr. Anil Kumar Mishra

India

Dr. Amit K. Tiwari

USA

Dr. Pia Vogel

USA

Dr. Jayachandra Ramapuram

USA

Dr. F. Scott Hall

USA

Dr. Frederick E. Williams

USA

Dr. Pravin Shende

India

 

Dr. Prabhat Arya

India

Dr. Ritu Chakravarti

USA

Dr. David Terrero

USA

Dr. C. Kartikeyan

India

Dr. S. H. Sagar Boddu

UAE

About Indore

Indore is the largest conglomerate of the state of Madhya Pradesh in India. It bears testimony to both historical lineages and ultra-modern economic development.

It is a fascinating city with a blend of a rich cultural and historical heritage hosting a wide range of styles of the Maratha, Mughal, Holkar and British era. Chhatris, Laal Bag Palace, Kanch Mandir are cues of its architectural excellence.

With a rich culture and heritage for its backbone, Indore is always a forerunner when it came to city planning or progressive education. Situated on one of India’s oldest pilgrimage routes from Mahakaal at Ujjain on river Kshipra, to Omkareshwar on the river Narmada and onwards to Rameshwaram, Indore is embellished by several forts and rocky shrines: Mandu, Dewas, Maheshwar, Omkareshwar being the prominent ones. Today, Indore is one of the fastest growing economies of India with varied industrial sectors such as automobiles, IT, pharmaceuticals, textiles and education hub.

About SKIPER, Indore

Shivajirao Kadam Institute of Pharmaceutical Education and Research has been established by Transnational Knowledge Society and promoted by Shivajirao Kadam Group of Institutions with the mission to set up the institute with academic excellence by imparting education through high-quality infrastructure and technologies in pharmaceutical sciences.

The vision of our Institute is to become an eminent institute by providing excellent pharmaceutical education and research to improve healthcare needs of Community and Technological aspects of industries. The Institute provide professional environment and develop pharmacy professionals as responsible citizens of a society with ethical values.

The Institute is committed to developed Skills to create innovation and bring the transformation among the young minds to become global leader in pharmaceuticals.